News Articles

Vince Ippolito says the bookbuild for the placement closed with strong support from existing and new shareholders. Photo: Botanix

Health 17 Feb 2026

Botanix shares fall amid $45m raising

Shares in Botanix have dropped more than 40 per cent after the West Perth biotech announced a $45 million capital raising, but at a significant discount to its last traded price.

Nedlands-based medtech company Proteomics has appointed a new managing director and chief executive. Photo: Proteomics.

Health 30 Jan 2026

How WA medical stocks fared last quarter

Several WA-based ASX-listed medical companies hit key milestones this quarter, signalling a strong year ahead for the sector.

Bulls N' Bears 11 Jul 2025

ASX Runners of the Week: Yandal, Imagion, Falcon & Bayan

This week's Bulls N' Bears ASX Runners of the Week is… Yandal Resources, after the company identified a gold discovery of potentially massive scale in one of WA's prolific gold belts. Imagion shot up on positive talks with the US FDA on its Phase 2 breast cancer imaging technology, Falcon intercepted some of the highest grade gold in Australian drilling this year and Bayan scooped up a strategic rare earths project next to the world-class Mountain Pass mine.

Botanix Pharmaceuticals executive chair Vince Ippolito. Credit: Botanix Pharmaceuticals.

Technology, Innovation & Science 15 Apr 2025

Botanix taps investors for $40m

Vince Ippolito-chaired Botanix will ask investors for $40 million as it eyes an expansion of its US offerings following a successful first few months in the market.

Health 17 Dec 2024

Botanix’s Sofdra hits the market

ASX-listed Botanix has shipped the first batch of Sofdra prescriptions, marking a milestone moment as it shifts towards becoming a revenue generating pharmaceuticals company.

Health 21 Jun 2024

Botanix taps investors for $70m

Leederville-based medical dermatology company Botanix has announced it will tap investors for $70 million to fund the launch of its recently US Food and Drug Administration approved Sofdra gel.

Health 20 Jun 2024

Botanix receives FDA approval for Sofdra

Leederville-based medical dermatology company Botanix has received US Food and Drug Administration approval for its Sofdra gel, used to treat excessive underarms sweating.

Deals 27 Nov 2023

Botanix taps investors for $13.5m

Clinical dermatology company Botanix Pharmaceuticals is tapping investors for $13.5 million to help fund the commercial launch of its lead treatment.

Appointments 25 Aug 2023

Board Moves August 25, 2023

Our board moves wrap includes Jeremy Robinson, Howie McKibbon, Simon Acomb, Ranko Matic, Vicki Krause, Bob McKinnon, Margaret Kennedy, Michelle Tierney, Greg Wall, and Tony Lennon.

Deals 21 Jul 2023

Botanix secures $12.5m placement

Botanix Pharmaceuticals has secured commitments from investors and is on track to raise $12.5 million via a placement to fund the buyout of financial obligations owed to another company.

Appointments 17 Apr 2023

Board Moves April 17, 2023

Our board moves wrap includes Susan Park, Simon Robertson, Richard Clayton, Mike Brook, Matthew Smith, Thomas Hanly, and Denning Chong.

Deals 05 Apr 2023

Botanix to raise $10m

Botanix Pharmaceuticals has secured commitments from investors to raise $10 million through a placement to develop its leading product.

Health 07 Nov 2022

Healthtech banks on rising numbers

The commercial side of life sciences may have reached a critical mass in WA.

Technology, Innovation & Science 04 May 2022

Botanix shares lifted after inking first deal

A Perth-based pharmaceutical founded by 40under40 winner Matt Callahan has acquired its first product in a bid to manoeuvre from research and development status to revenue-generating.

Appointments 22 Mar 2022

Board Moves March 22, 2022

Our board moves wrap includes Daniel Sharp and Damon Cox.

Appointments 01 Mar 2021

Board Moves March 1, 2021

Our board moves wrap includes Brian Thomas, Annie Guo, Peter Ingram, Michael Thurn, Jeremy Whybrow, Patrick Glovac, and Vaughn Taylor.

Agribusiness 15 Dec 2020

Research a driver for cannabis

The strong growth of the medicinal cannabis industry will need to be supported by research for the sector to take the next step.

Technology, Innovation & Science 14 Sep 2020

More than Linear growth for drug trials in COVID-free WA

Perth's largest drug testing company plans to nearly double capacity as WA attracts attention from global pharmaceutical companies.

Appointments 11 Feb 2020

Board Moves February 11, 2020

Matt Callahan has re-joined the board of Botanix Pharmaceuticals as an executive director following the decision by Robert Towner to step down as non-executive director.

Health 23 Oct 2019

Botanix shares plunge on study results

Shares in Bentley-based medical cannabis company Botanix Pharmaceuticals have nearly halved, after it released the results of its clinical trial for acne treatment.

Appointments 23 Aug 2019

Board Moves August 23, 2019

Our daily board moves wrap includes Matt Callahan, Simon Paull, Alan Armstrong, David Rich, and Patrick Glovac.

Appointments 01 Aug 2019

Appointments August 1, 2019

Our weekly appointment wrap includes Eric Lumsden, John Langoulant, Michael Court, Nicole Lockwood, Terry Agnew, Kerryl Bradshaw, Andrea Sutton, Wayne Zekulich, Keith Hirschman, Tony Sheard, Alex Ogg, Nicholas Chapple, Paul Pryde, Shane Ogilvie, Saschelle Blake, Brett Heather, Richard Peterson, and Howie McKibbon.

Health 01 Aug 2019

Botanix raises $40m

Botanix Pharmaceuticals is set to raise $40 million via a share placement, less than two months after it released studies suggesting its cannabis compound could be used as an antimicrobial to mitigate superbugs.

Appointments 21 Jul 2019

Board Moves July 15-19, 2019

This weekly board moves wrap includes Vince Ippolito, Stewart Washer, Matthew Madden, Jason Stirbinskis, Rob McDonald, Evan Cranston, Tolga Kumova, Dror Nagel, Leigh Junk, Maggie Niewidok, Justin Mouchacca, Laurie Marsland, Michael Hardy, Matthew Carr, Cameron Henry, Robert Sckalor, and David McArthur.

Technology, Innovation & Science 20 May 2019

Botanix lines up exec chair appointment

Botanix Pharmaceuticals has appointed Vince Ippolito as its president in the US, and subject to shareholder approval, he will also assume the role of executive chairman for the company.

Technology, Innovation & Science 08 Feb 2019

Graham Griffiths passes away

Perth's business community was shocked today to learn of the sudden passing of Graham Griffiths, who was chairman of five technology companies and had been a mentor to many people in the tech sector.

Deals 20 Jun 2018

Local tech firms raise $13m

Two local biotech companies have announced capital raisings today, with Botanix Pharmaceuticals tapping investors for $8 million, while Roto-Gro International has boosted its coffers with a $4.5 million raising.

Technology, Innovation & Science 26 Apr 2018

Local tech raisings down

Local startups and young technology companies registered a big decline in funds raised in the March quarter compared to December, according to the latest report from tech sector analysts Techboard.

Deals 12 Feb 2018

Corporate finance deals Feb 5 to 9 2018

Okapi Resources Limited (ASX:“OKR”) (“Okapi” & “Company”) is pleased to announce that, further to its announcement of 24 January 2018, it has completed the issue of 2,142,857 fully paid ordinar

Deals 05 Feb 2018

Botanix in $15m raising

Medical dermatology company Botanix Pharmaceuticals has raised $15 million through a strongly supported share placement, with the proceeds set to be spent on developing its lead product for acne.

Education 29 Jan 2018

Botanix up on study results

Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.

Deals 05 Apr 2017

Botanix raises $7m to develop products

Biotech Botanix Pharmaceuticals has raised $7.4 million in a placement of new shares to help it fund the further development of its dermatology products that contain a synthetic form of the cannabis compound, cannabidiol.

Technology, Innovation & Science 15 Jul 2016

Botanix makes ASX debut

Medical dermatology company Botanix Pharmaceuticals has enjoyed healthy gains on its first day of trading on the ASX, after completing a reverse takeover of Bone Medical.

News Articles for Botanix Pharmaceuticals

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark